DOCTOR'S VIEW ARCHIVE
Diabetes Update from the American Diabetes Association National Meeting
Index to the Daily Updates:
Day 5 (Tuesday, June 14)
Day 4 (Monday, June 13)
Day 3 (Sunday, June 12)
Day 2 (Saturday, June 11)
Day 1 (Friday, June 10)
The American Diabetes Association annual scientific symposia is being held this year in San Diego. An estimated 15,000 clinicians, scientists, nutritionists and educators are expected to attend. The goal of this meeting is to allow for the exchange of new scientific ideas, to discuss the development of new products and medications and provide a forum to educate those involved in diabetes care on the latest concepts and breakthroughs.
Often these types of national meetings are cyclic. A few years go by without much buzz - and then a year or two follow with something incredibly significant like a breakthrough in understanding the mechanisms disease process, a class of drug targeting a new area for treatment or perhaps the identification of a new genetic link to explore.
This year promises to be an exciting one. There are new modalities for insulin delivery such as inhaled insulin which will be discussed throughout the session. There are brand new classes of drugs for the treatment of diabetes that have never been available before that are going to be reviewed in detail, and the important link between obesity and type 2 diabetes is another area that much of meeting will be devoted to. My goal is to report back to you daily on some of the major topics discussed at the ADA.
I hope you find these reports informative and interesting and I hope they give you some idea of what the thousands of people involved with the treatment of diabetes are buzzing about. Maybe some of this information will help you open a dialogue with your physician about your specific treatment options.
#2 Day 1 - Friday, June 10
First Day Highlights
Visit our Diabetes center for the latest updates on diabetes treatments and news.
Get the latest health and medical information delivered direct to your inbox FREE!